Pricing Log in Create free account

Abivax SA Sponsored ADR (ABVX) vs Caris Life Sciences,�Inc. (CAI)

Abivax SA Sponsored ADR and Caris Life Sciences,�Inc. are both Biotechnology companies. Caris Life Sciences,�Inc. is the larger, with a market value of $9.0B against $8.1B — 1.1× the size. Abivax SA Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Caris Life Sciences,�Inc. trades at 81.3×. Caris Life Sciences,�Inc. has the higher net margin (8.15% vs 0.00%) and the higher return on invested capital (50.0% vs 0.00%). Across the 14 metrics below, Caris Life Sciences,�Inc. leads on 12 and Abivax SA Sponsored ADR on 2.

Valuation

Metric ABVX CAI Biotechnology median
P/E n/m 81.30 8.50
P/S n/m 8.74 9.71
P/B 16.42 14.61 2.13
Price to free cash flow n/m 69.74 20.82
EV/EBITDA n/m 45.80 0.64
EV/Sales n/m 8.33 9.21
Earnings yield (6.90%) 1.23% (33.15%)
Free cash flow yield (3.23%) 1.43% (25.50%)

Profitability

Metric ABVX CAI Biotechnology median
Gross margin 0.00% 69.66% 65.16%
Operating margin 0.00% 15.49% 0.00%
Net margin 0.00% 8.15% 0.00%
Free cash flow margin 0.00% 12.53% 0.00%
Return on equity (249.78%) 15.45% (56.36%)
Return on assets (137.67%) 7.39% (48.04%)
Return on invested capital 0.00% 49.95% 0.00%

Growth

Metric ABVX CAI Biotechnology median
Revenue growth (TTM) — 96.36% 6.02%
EPS growth (last fiscal year) (80.20%) 59.45% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABVX CAI Biotechnology median
Debt to equity 0.00 0.66 0.00
Current ratio 5.97 5.53 4.72
Net debt to EBITDA 2.19 (5.23) 0.96

Dividend

Metric ABVX CAI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABVX CAI Biotechnology median
Market cap 8.09b 8.98b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack